开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
欧盟委员会主席冯德莱恩:(在对利雅得机场的袭击后表示)我们全力支持沙特阿拉伯人民及海湾伙伴。
2026-10-09
欧盟委员会主席冯德莱恩:(在对利雅得机场的袭击后表示)我们全力支持沙特阿拉伯人民及海湾伙伴。
返回
其他消息
2026-10-09
At its Oct. 9 H1 2026 results briefing, Bloomage BioTechnology said it is expanding beyond its hyaluronic acid strength into PDRN/PN, recombinant collagen, human milk oligosaccharides (HMOs), ergothioneine and salidroside. Some of those new bioactives have entered commercialization and have begun to contribute revenue. In the raw-materials segment, PDRN and recombinant collagen are gradually becoming new growth drivers.
At its Oct. 9 H1 2026 results briefing, Bloomage BioTechnology said it is expanding beyond its hyaluronic acid strength into PDRN/PN, recombinant collagen, human milk oligosaccharides (HMOs), ergothioneine and salidroside. Some of those new bioactives have entered commercialization and have begun to contribute revenue. In the raw-materials segment, PDRN and recombinant collagen are gradually becoming new growth drivers.
2026-10-09
European equities opened on Oct 9: Germany's DAX 30 +151.78 pts (+0.61%) at 24,958.75; UK FTSE 100 +85.05 pts (+0.81%) at 10,526.65; France CAC 40 +54.15 pts (+0.70%) at 7,783.84; EUROSTOXX 50 +36.62 pts (+0.60%) at 6,163.35; Spain IBEX 35 +189.52 pts (+1.00%) at 19,118.42; Italy FTSE MIB -325.75 pts (-0.65%) at 49,646.50.
European equities opened on Oct 9: Germany's DAX 30 +151.78 pts (+0.61%) at 24,958.75; UK FTSE 100 +85.05 pts (+0.81%) at 10,526.65; France CAC 40 +54.15 pts (+0.70%) at 7,783.84; EUROSTOXX 50 +36.62 pts (+0.60%) at 6,163.35; Spain IBEX 35 +189.52 pts (+1.00%) at 19,118.42; Italy FTSE MIB -325.75 pts (-0.65%) at 49,646.50.
Chat with us
, powered by
LiveChat